Light-to-moderate alcohol consumption has been previously associated with a lower risk of acute myocardial infarction (AMI) and mortality. The association of changes in drinking behavior after an AMI with health status and long-term outcomes is unknown. Using a prospective cohort of patients with AMI evaluated with the World Health Organization’s Alcohol Use Disorders Identification Test, we investigated changes in drinking patterns in 325 patients who reported moderate drinking at the time of their AMI. One-year alcohol consumption, disease-specific (angina pectoris and quality of life) and general (mental and physical) health status and rehospitalization outcomes, and 3-year mortality were assessed. Seattle Angina Questionnaire Angina Frequency and Quality of Life, Short Form-12 Mental and Physical Component Summary Scales were modeled using multivariable hierarchical linear models within site. Of the initial 325 moderate drinkers at baseline, 273 (84%) remained drinking and 52 (16%) quit. In fully adjusted models, Physical Component Scale scores (beta 6.47, 95% confidence interval 3.73 to 9.21, p <0.01) were significantly higher during follow-up in those who remained drinking. Persistent moderate drinkers had a trend toward less angina (relative risk 0.65, 95% confidence interval 0.39 to 1.10, p = 0.11), fewer rehospitalizations (hazard ratio 0.79, 95% confidence interval 0.44 to 1.41, p = 0.42), lower 3-year mortality (relative risk 0.75, 95% confidence interval 0.23 to 2.51, p = 0.64), and better disease-specific quality of life (Seattle Angina Questionnaire Quality of Life, beta 3.88, 95% confidence interval −0.79 to 8.55, p = 0.10) and mental health (Mental Component Scale, beta 0.83, 95% confidence interval −1.62 to 3.27, p = 0.51) than quitters. In conclusion, these data suggest that there are no adverse effects for moderate drinkers to continue consuming alcohol and that they may have better physical functioning compared to those who quit drinking after an AMI.
After an acute myocardial infarction (AMI), moderate alcohol drinkers may alter their alcohol consumption in response to such a life-changing event. To date, there have been no studies describing the drinking patterns and associated outcomes of moderate drinkers after an AMI. Given the potential benefits of moderate alcohol consumption on minimizing ischemic events, we sought to describe the proportion of patients who drank moderate amounts of alcohol before their AMI and then quit compared to those who continued consuming alcohol after their AMI. We then examined the association of continued alcohol consumption with cessation on 1-year disease-specific (angina pectoris and quality of life) and general (mental and physical) health status outcomes, 1-year rehospitalizations, and 3-year mortality rates.
Methods
From January 1, 2003, to June 28, 2004, 2,498 patients with AMI were recruited into the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery (PREMIER) study from 19 US hospitals. Details of the study have been published elsewhere. Eligible patients were ≥18 years old with enzymatic evidence supporting the diagnosis of AMI and had prolonged (>20 minutes) ischemic signs/symptoms or electrocardiographic ST changes. Institutional research board approval was obtained at each participating institution and patients signed informed consent for baseline and follow-up interviews. Trained data collectors interviewed patients during hospitalization and abstracted charts that included data regarding patients’ presentation, clinical history, and treatment during hospitalization. A centralized follow-up center performed follow-up interviews by telephone at 1 month and 6 and 12 months after patients’ MI. Nondrinkers and binge drinkers were removed from the analysis because they were not the focus of this study.
Alcohol consumption was assessed by patient self-report at the time of a confirmed AMI and during follow-up interviews. Three brief screening questions of the World Health Organization’s Alcohol Use Disorders Identification Test were used at baseline and follow-up to quantify the frequency of drinking, how many drinks were consumed in 1 day, and binge drinking (≥6 drinks at a single time). Moderate drinking was defined as drinking a minimum of 2 to 4 times/month with no more than 1 drink to 4 drinks per occasion, thus averaging <1 drink/day. Binge drinkers were excluded because binge drinking has been associated with adverse cardiovascular and all-cause mortality and is not supported by any medical evidence. Thus, of the initial 2,498 patients enrolled in PREMIER, only the 325 moderate drinkers were retained to address our study question of the changes in drinking patterns and outcomes.
The analyzed outcomes were (1) 1-year disease-specific and general health status, (2) 1-year rehospitalization, and (3) 3-year mortality assessed after the 1-year interview. To quantify patients’ health status, the disease-specific Seattle Angina Questionnaire (SAQ) and the generic Short Form-12 (SF-12) were administered at the time of enrollment and at the 1-year follow-up interview. The SAQ is a 19-item questionnaire measuring patients’ perspectives of how their coronary disease affects health status domains. The SAQ is valid, reliable, sensitive to clinical changes, and prognostic of subsequent mortality and admissions for acute coronary syndromes. For the purposes of this study, scores on the Angina Frequency and Quality of Life subscales were used, which range from 0 to 100, with higher scores indicating less angina and better quality of life. Angina was dichotomized into any angina versus no angina due to the skewed distribution of angina because most patients were angina free 1 year after their AMI and in recognition of the clinical goal to have patients attain complete angina relief. The SF-12 is a valid and reliable measurement of patients’ general functional status and generates mental and physical component scores (Mental Component Scale and Physical Component Scale). Rehospitalization data were collected by self-report during each patient telephone interview throughout the 1-year follow-up. Mortality data were collected by querying the Social Security Death Master File in addition to information obtained from family members through follow-up interviews. Baseline for mortality was the 1-year interview date because a patient had to survive to the 1-year interview to assess changes in alcohol use.
Descriptives between categories of change in alcohol use were compared to chi-square or Fisher’s exact tests for categorical variables or to t tests for continuous variables, as appropriate. Kaplan-Meier estimates were used for 1-year rehospitalization, 3-year mortality, and creation of Kaplan-Meier survival curves to compare time to outcomes with the log-rank test. Multivariable models adjusted for baseline health status (in health status models only), age, gender, Caucasian race, smoking, diabetes, renal failure, and congestive heart failure. SAQ Quality of Life subscale, SF-12 Mental Component Scale, and SF-12 Physical Component Scale were modeled using multivariable hierarchical linear models within a site and estimates are reported as beta regression weights and 95% confidence intervals. The hierarchical model structure accounted for clustering of patients within a site. Angina, rehospitalization, and mortality were modeled using multivariable hierarchical modified Poisson regression within a site. Typical analyses often use logistic regression to estimate adjusted odds ratios, which are then interpreted as relative risks. However, in this study the events being modeled (presence of angina and adverse outcomes) were not rare, in which case odds ratios are poor estimates of relative risks. To address this issue, we estimated adjusted relative risks directly using a modified Poisson regression model. These estimates are reported as relative risks and 95% confidence intervals. Three-year mortality and 1-year rehospitalization were modeled using time-to-event multivariable proportional hazards regression stratified by site. Results are reported as hazard ratios and 95% confidence intervals. All tests for statistical significance were 2-tailed with an alpha level of 0.05. All analyses were conducted using SAS 9.1.3 (SAS Institute, Cary, North Carolina) and R 2.6.0.
Results
Of the initial 325 patients who were included in the analysis, 273 (84%) continued to drink, and 52 (16%) quit ( Figure 1 ). Most patients were Caucasian, men, and >50 years of age. A larger percentage of the quitters had a history of smoking, diabetes, congestive heart failure, and chronic renal failure compared to those who continued to drink alcohol ( Table 1 ).
| Persistent Moderate Drinkers | Quitters | p Value | |
|---|---|---|---|
| (n = 273) | (n = 52) | ||
| Unadjusted baseline data | |||
| Age (years) | 61 ± 11.7 | 62 ± 13.2 | 0.550 |
| Caucasian | 256 (94%) | 36 (69%) | <0.001 |
| Men/women | 227 (83%)/46 (17%) | 40 (77%)/12 (23%) | 0.282 |
| Smoked within previous 30 days | 63 (23%) | 17 (33%) | 0.144 |
| Diabetes mellitus | 28 (10%) | 7 (14%) | 0.494 |
| Congestive heart failure | 7 (3%) | 6 (12%) | 0.009 |
| Chronic renal failure | 6 (2%) | 2 (4%) | 0.619 |
| SAQ-assessed angina (any vs none) at baseline | 137 (50%) | 29 (56%) | 0.460 |
| SAQ-assessed quality of life (baseline) | 67 ± 21.0 | 61 ± 23.5 | 0.055 |
| SF-12 Physical Component Scale score (baseline) | 48 ± 10.8 | 46 ± 11.0 | 0.282 |
| SF-12 Mental Component Scale score (baseline) | 53 ± 9.0 | 50 ± 11.9 | 0.022 |
| Unadjusted outcome data | |||
| SAQ-assessed presence of angina (any vs none) at 1 year | 35 (13%) | 12 (23%) | 0.055 |
| SAQ-assessed quality of life at 1 year | 87 ± 14.5 | 81 ± 23.7 | 0.015 |
| SF-12 Physical Component Scale score (1 year) | 50 ± 8.9 | 41 ± 12.0 | <0.001 |
| SF-12 Mental Component Scale score (1 year) | 54 ± 7.3 | 52 ± 10.0 | 0.061 |
| Rehospitalizations (1 year) ⁎ | 75 (28%) | 18 (35%) | 0.26 |
| Mortality (3 years) ⁎ | 16 (6.0%) | 5 (10%) | 0.3 |
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
